A citation-based method for searching scientific literature

Mikko Loukovaara, Annukka Pasanen, Ralf Bützow. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interpretation of somatic POLE mutations in endometrial carcinoma.
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, Jessica N McAlpine, Remi Nout, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau,[...]. J Pathol 2020
103
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
Brooke E Howitt, Sachet A Shukla, Lynette M Sholl, Lauren L Ritterhouse, Jaclyn C Watkins, Scott Rodig, Elizabeth Stover, Kyle C Strickland, Alan D D'Andrea, Catherine J Wu,[...]. JAMA Oncol 2015
397
100

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
Aline Talhouk, Lien N Hoang, Melissa K McConechy, Quentin Nakonechny, Joyce Leo, Angela Cheng, Samuel Leung, Winnie Yang, Amy Lum, Martin Köbel,[...]. Gynecol Oncol 2016
104
100

Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.
Soyoun Rachel Kim, Alicia Tone, Raymond H Kim, Matthew Cesari, Blaise A Clarke, Lua Eiriksson, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn,[...]. Gynecol Oncol 2021
4
100

Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma.
Pierluigi Benedetti Panici, Stefano Basile, Maria Giovanna Salerno, Violante Di Donato, Claudia Marchetti, Giorgia Perniola, Antonio Palagiano, Alessandra Perutelli, Francesco Maneschi, Andrea Alberto Lissoni,[...]. Am J Obstet Gynecol 2014
43
100

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Young Shin Chung, Ha Young Woo, Jung-Yun Lee, Eunhyang Park, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim. Am J Obstet Gynecol 2021
19
100

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Marthe M de Jonge, Aurélie Auguste, Lise M van Wijk, Philip C Schouten, Matty Meijers, Natalja T Ter Haar, Vincent T H B M Smit, Remi A Nout, Mark A Glaire, David N Church,[...]. Clin Cancer Res 2019
73
100

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
177
100

Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Anne M Kolehmainen, Annukka M Pasanen, Riitta L Koivisto-Korander, Ralf C Bützow, Mikko J Loukovaara. Eur J Obstet Gynecol Reprod Biol 2021
8
100

Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Dario R Roque, Liza Makowski, Ting-Huei Chen, Naim Rashid, D Neil Hayes, Victoria Bae-Jump. Gynecol Oncol 2016
21
100

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
327
100

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
Bengt Sorbe, György Horvath, Håkan Andersson, Karin Boman, Caroline Lundgren, Birgitta Pettersson. Int J Radiat Oncol Biol Phys 2012
105
100

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Alain G Zeimet, Daniel Reimer, Monica Huszar, Boris Winterhoff, Ulla Puistola, Samira Abdel Azim, Elisabeth Müller-Holzner, Alon Ben-Arie, Léon C van Kempen, Edgar Petru,[...]. J Natl Cancer Inst 2013
144
100

Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management.
Eman Abdulfatah, Erin Wakeling, Sharif Sakr, Khaleel Al-Obaidy, Sudeshna Bandyopadhyay, Robert Morris, Gerald Feldman, Rouba Ali-Fehmi. Gynecol Oncol 2019
28
100

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
100

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.
Carien L Creutzberg, Remi A Nout, Marnix L M Lybeert, Carla C Wárlám-Rodenhuis, Jan J Jobsen, Jan-Willem M Mens, Ludy C H W Lutgens, Elisabeth Pras, Lonneke V van de Poll-Franse, Wim L J van Putten. Int J Radiat Oncol Biol Phys 2011
185
100

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.
P Blake, Ann Marie Swart, J Orton, H Kitchener, T Whelan, H Lukka, E Eisenhauer, M Bacon, D Tu, M K B Parmar,[...]. Lancet 2009
403
100


Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations.
Chad A Hamilton, Bhavana Pothuri, Rebecca C Arend, Floor J Backes, Paola A Gehrig, Pamela T Soliman, J Spencer Thompson, Renata R Urban, William M Burke. Gynecol Oncol 2021
17
100

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
Thomas Hogberg, Mauro Signorelli, Carlos Freire de Oliveira, Roldano Fossati, Andrea Alberto Lissoni, Bengt Sorbe, Håkan Andersson, Seija Grenman, Caroline Lundgren, Per Rosenberg,[...]. Eur J Cancer 2010
308
100

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
331
100

Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Casper Reijnen, Heidi V N Küsters-Vandevelde, Clemens F Prinsen, Leon F A G Massuger, Marc P M L Snijders, Stefan Kommoss, Sara Y Brucker, Janice S Kwon, Jessica N McAlpine, Johanna M A Pijnenborg. Gynecol Oncol 2019
50
100


Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
C L Creutzberg, W L van Putten, P C Koper, M L Lybeert, J J Jobsen, C C Wárlám-Rodenhuis, K A De Winter, L C Lutgens, A C van den Bergh, E van de Steen-Banasik,[...]. Lancet 2000
100

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
G J Freeman, A J Long, Y Iwai, K Bourque, T Chernova, H Nishimura, L J Fitz, N Malenkovich, T Okazaki, M C Byrne,[...]. J Exp Med 2000
100

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.
Felix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C Blake Gilks, David G Huntsman, Bernhard Krämer, Sara Y Brucker,[...]. Br J Cancer 2018
51
100


Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Marcus E Randall, Virginia Filiaci, D Scott McMeekin, Vivian von Gruenigen, Helen Huang, Catheryn M Yashar, Robert S Mannel, Jae-Weon Kim, Ritu Salani, Paul A DiSilvestro,[...]. J Clin Oncol 2019
153
100


Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
R A Nout, V T H B M Smit, H Putter, I M Jürgenliemk-Schulz, J J Jobsen, L C H W Lutgens, E M van der Steen-Banasik, J W M Mens, A Slot, M C Stenfert Kroese,[...]. Lancet 2010
705
100

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
370
100

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
T Bosse, R A Nout, E Stelloo, E Dreef, H W Nijman, I M Jürgenliemk-Schulz, J J Jobsen, C L Creutzberg, V T H B M Smit. Eur J Cancer 2014
97
100

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Casey M Cosgrove, David L Tritchler, David E Cohn, David G Mutch, Craig M Rush, Heather A Lankes, William T Creasman, David S Miller, Nilsa C Ramirez, Melissa A Geller,[...]. Gynecol Oncol 2018
60
100

PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
Annukka Pasanen, Terhi Ahvenainen, Teijo Pellinen, Pia Vahteristo, Mikko Loukovaara, Ralf Bützow. Am J Surg Pathol 2020
37
100

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
246
100

TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
Antonio Raffone, Antonio Travaglino, Massimo Mascolo, Luigi Carbone, Maurizio Guida, Luigi Insabato, Fulvio Zullo. Gynecol Oncol 2019
92
100

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo,[...]. Lancet Oncol 2018
264
100

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
130
100

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
341
100

Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
Jean H Siedel, Kari L Ring, Wei Hu, Robert L Dood, Ying Wang, Keith Baggerly, Kathleen M Darcy, Thomas P Conrads, Shannon Gallagher, Placede Tshiaba,[...]. Gynecol Oncol 2021
7
100


Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial.
Ana Oaknin, Anna V Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, Jubilee Brown, Maria-Pilar Barretina-Ginesta, Victor Moreno, Adriano Gravina, Cyril Abdeddaim,[...]. JAMA Oncol 2020
94
100

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
106
100

Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.
Angeles Alvarez Secord, Vic Hasselblad, Vivian E Von Gruenigen, Paola A Gehrig, Susan C Modesitt, Victoria Bae-Jump, Laura J Havrilesky. Gynecol Oncol 2016
85
100

Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.
Sharyn N Lewin, Thomas J Herzog, Nicanor I Barrena Medel, Israel Deutsch, William M Burke, Xuming Sun, Jason D Wright. Obstet Gynecol 2010
194
100


Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
100

L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Thanh H Dellinger, David D Smith, Ching Ouyang, Charles D Warden, John C Williams, Ernest S Han. Gynecol Oncol 2016
55
100

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma.
Annukka Pasanen, Mikko Loukovaara, Terhi Ahvenainen, Pia Vahteristo, Ralf Bützow. PLoS One 2021
2
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.